N

Nykode

Sustainability Report and Carbon Intensity Rankings

Is Nykode doing their part?

Their DitchCarbon score is 30

Nykode has a DitchCarbon Score of 30 out of 100, indicating a lower performance in sustainability measures. This score suggests that the company’s carbon intensity is relatively high, reflecting a need for improvement in reducing emissions. Efforts to enhance sustainability and decrease carbon intensity are essential for Nykode to improve its score.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Nykode operates within the research and development sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Medium

High

Very high

Nykode, located in Norway, benefits from the country’s very low carbon intensity, indicating strong sustainability efforts. The company’s operations are thus likely to have a lower environmental impact due to the clean energy practices prevalent in the region.

Unlock 30+ emissions intelligence data points

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on Nykode

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

21.36%

...this company is doing 21.36% worse in emissions than the industry average.

Nykode Therapeutics, located in Norway, operates within the research and development sector of the biotechnology industry. Founded in 2007, the company specializes in the development of innovative vaccine technologies, particularly its proprietary Vaccibody molecule platform. This platform is designed to pioneer advancements in the field of medicine, offering potential new solutions for vaccine development.

emission intelligence's platform recommendations for Nykode

Gibson Dunn should foster sustainability practices throughout their supply chain to achieve a significant reduction in their Scope 3 emissions.

Bad news, Nykode hasn't committed to SBTi goals yet

Nykode has pledged to align with the Science Based Targets initiative by setting emissions reduction targets consistent with climate science. This commitment means the company is taking actionable steps to significantly reduce its carbon footprint and contribute to global efforts in limiting global warming.
Not participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Looking for a specific company?

Search our company directory or contact us for custom data requests.